Purpose: There is no consensus whether the posterior cruciate ligament (PCL)should be preserved (CR) or sacrificed (CS) during primary total knee replacement (TKR). The purpose of this study was to compare the greater than 10 year survivorship and health related outcomes of CR and CS TKRs using a single implant system.

Method: Between 1996 and 2000, 478 Genesis II Primary TKRs were inserted in 414 patients. Excluding those with a primary diagnosis other than osteoarthritis, body mass index greater then 40, history of prior patellectomy, fusion or osteotomy, 358 cases in 310 patients were included. 134 (37%) had a PCL preserving (CR) and 224 (63%) had a PCL sacrificing implant (CS). The two patient cohorts were compared for Kaplan-Meier survivorship, health-related outcomes (Knee Society scores, WOMAC, SF-12), range of motion (ROM) and radiographic loosening or wear.

Results: Mean follow-up was 11.87±1.04 years for CR and 10.96±0.87 years for CS (p=0.001). Four cases were revised for infection. No significant differences were noted between the CR and CS Genesis II cohorts at 10 year Kaplan-Meier survivorship excluding infections (CR 0.984±0.011, CS 0.986±0.008, p=0.30). Overall revisions were two for CR (1.5%, no infections) and seven for CS (1.7%, four for infection; 1.3% excluding infections). Revision rates were not significantly different between groups including or excluding infections (p=0.493 and p=1.00 respectively). CS had significantly greater postoperative ROM than CR (CS=114.20±13.60, CR=111.35±12.38, p=0.024). At 10 years, no differences were observed in satisfaction, health-related outcomes or radiographic wear/loosening. Crepitus was reported more frequently in CS design.

Conclusion: Most studies comparing PCL sacrificing (CS) versus retaining (CR) TKRs are short term. In this large, long term, single implant CR versus CS study, no differences were found in Kaplan-Meier survivorship, health-related outcomes or patient satisfaction. The CS design had more range of motion, but also a higher incidence of peripatellar crepitus than the CR design. We conclude that both CR and CS TKR designs can yield excellent long term clinical outcomes.

Purpose: High contact stresses and wear after total knee replacement (TKR) has been a problem. Mobile bearing TKRs have been advocated as a means to increase load bearing area, reduce contact stresses and minimize wear. The purpose of this study was to compare two, large, consecutive cohorts of TKR patients with greater than 10 years follow-up, one with a fixed bearing and one with a mobile bearing design.

Method: One hundred and three SAL II mobile bearing TKR’s were compared to a gender, age, BMI and time from surgery matched fixed bearing Genesis II cohort of equal size. All surgeries were performed between September 1993 and December 2000 (average follow-up, 11.64±1.64 years). Inclusion criteria included patients with osteoarthritis of the knee. Exclusion criteria included revision arthroplasty, inflammatory arthritis, a prior osteotomy or a prior patellectomy. The > 10 year Kaplan-Meier survivorship, health-related outcomes (Knee Society scores, WOMAC and SF-12), radiographs and retrieved implants for the fixed and mobile bearing TKR cohorts were compared.

Results: Fixed bearing TKRs demonstrated better 10 year Kaplan-Meier survivorships for any re-operation, 1.000±0.000 compared to 0.969±0.018 for mobile bearings (Genesis II and SAL I/II respectively). Revision rates were significantly different between groups with fixed bearing having no revisions and mobile four revisions (3.9%). No cases were revised for sepsis. Mobile bearing revisions were for pain (1), patellar maltracking (1), polyethylene wear (1) and aseptic loosening (1). At 10 years, health-related outcomes were similar between the two cohorts. Fixed bearing TKRs demonstrated more range of motion (111.42±12.76 vs 107.19±14.74 degrees) although not significant (p=0.052). Wear was more frequently noted in mobile bearing TKRs on > 10 year radiographs.

Conclusion: In this comparison of two contemporary TKRs, the fixed bearing TKR outperformed the mobile bearing TKR.

Purpose: The Synergy femoral component was introduced in late 1996 as a second generation titanium proximally porous-coated tapered stem with dual offsets (standard & high) to help better restore femoral offset at THR. The purpose of this prospective study was to evaluate the long-term (minimum 10 year) clinical and radiographic results and survivorship of this second-generation femoral component at our institution.

Method: From December 1996 to December 1999, 256 cementless Synergy femoral components were inserted and followed prospectively in 254 patients requiring THR. 185 were standard offset stems(72.3%) while 71 stems (27.7%) were high offset. The average follow-up was 11.2 years (range 10.0 to 12.9 years). Average age at index THR was 58.9 years (range 19 to 86 years). Two hundred eight stems had standard porous coating while 48 had additional HA coating. Fifty-two cases were either lost to follow-up or had died prior to 10 years follow-up. Patients were followed prospectively using validated clinical outcome scores (WOMAC, SF-12, Harris Hip scores) and radiographs. Kaplan-Meier survival analysis was performed.

Results: All health-related outcomes were significantly improved from pre-operative with a mean Harris Hip score and WOMAC at last follow-up of 91.6 and 81.8, respectively. From the initial 256 femoral stems inserted, only 5 stems have been revised. Two stems have been revised for infection. To date, only one stem has been revised due to subsidence at nine months following surgery likely, as a result of a calcar fracture occurring at the index THR. Two stems were revised for peri-prosthetic fracture as a result of patient falls at six months and 9.8 years post-op. Radiographic review of remaining stems in-situ identified no cases of loosening with all stems showing evidence of osseous integration. The Kaplan-Meier survivorship analysis of the femoral component, with revision for aseptic loosening, was 99.2%±0.008 at five, 10 and 12 years.

Conclusion: The Synergy femoral component, a second generation titanium proximally porous-coated tapered stem design with dual offsets, has demonstrated excellent clinical & radiographic results and long-term survivorship (99% at 10 years) at our institution.

Purpose: The purpose of this prospective blinded randomized control trial was to compare the stem migration of two cemented stem designs using radiostereometric analysis (RSA). This was essentially a safety study in which our hypothesis was that the newer design (CPCS, Smith and Nephew Inc) would demonstrate similar micro-motion to the well-established Exeter (Stryker) design.

Method: Thirty patients were consented and enrolled into a blinded RCT in which 15 patients received a dedicated RSA CPCS stem and 15 patients received a RSA Exeter stem. Both stems are collarless tapered polished cemented stems, the only difference being a slight lateral to medial taper with the CPCS design. Outcome measures were compared (Hip Society Score, WOMAC, SF-12). RSA analysis was conducted immediately postoperatively, at 6 weeks, 3 months, 6 months, 1 year and 2 years.

Results: No difference was found in any of the outcome measures pre-operatively or postoperatively. At 2 years, stem subsidence for the CPCS stem was approximately half that seen for the Exeter stem (0.565±0.189mm and 0.981±0.209mm respectively, p< 0.0001). In contrast, posterior (internal) rotation of the CPCS was approximately twice that of the Exeter stem (1.496±1.215° and 0.716±0.818° respectively, p=0.221). Other migration patterns were no different between stems.

Conclusion: As expected with this stem design, both stems showed some axial and rotational migration within the cement mantle. The subtle differences in design may explain the differences in migration patterns. Our data suggests that the newer CPCS design should perform well over the long-term.

Purpose: Metal-on-metal articulations are an increasingly popular choice as an alternate bearing surface in total hip arthroplasty (THA) and Resurfacing implants. One advantage of a metal-on-metal bearing is the use of larger diameter femoral heads with hip simulator data demonstrating reduced wear. We performed a prospective, multicentre, randomized, blinded clinical trial comparing 28mm to 36mm metal-on-metal bearings assessing multiple validated outcome measures and serum, erythrocyte and urine metal ions.

Method: Ninety-one patients were randomized to receive a metal-on-polyethylene (34), a 28mm metal-on-metal (25) or a 36mm metal-on-metal (32) insert. All patients received the same acetabular and femoral component. Patients were evaluated pre-operatively, at 6, 12 months and annually thereafter, including an evaluation of serum, erythrocyte and urine cobalt, chromium, and titanium, outcome measures (WOMAC, SF-12, Harris Hip Score) and radiographs.

Results: At a minimum two years follow-up there were no differences in WOMAC, SF-12, Harris Hip scores or radiographs. Patients receiving metal liners had significantly (p< 0.001) elevated metal ion measurements compared with the polyethylene control group, however there were no differences between the 28mm and 36mm metal-on-metal bearings (Median serum Co (mg/L): 0.14(poly), 0.77(28mm), 0.73(36mm). Median erythrocyte Co (mg/L): 0.11(poly), 0.42(28mm), 0.42(36mm). Median urine Co(mg/day): 0.44(poly), 4.55(28mm), 5.42(36mm)). (Median serum Cr(mg/L): 0.17(poly), 1.29(28mm), 0.91(36mm). Median erythrocyte Cr(mg/ L): 1.10(poly), 1.10(28mm), 1.20(36mm). Median urine Cr(mg/day): 0.27(poly), 1.92(28mm), 2.02(36mm)).

Conclusion: Both cobalt and chromium ion measurements were significantly elevated in the blood and urine of the patients randomized to receive the metal-on-metal bearings at all time intervals. There were no differences seen between the 28mm and 36mm metal-on-metal bearings, keeping all other variables identical. The larger diameter bearing therefore provides the potential clinical advantages of improved range of motion and stability, while providing a similar metal ion profile. While reduced wear is seen with larger diameter metal-on-metal bearings in-vitro, we could not demonstrate a reduction in blood or urine metal ion levels in-vivo.

Purpose: Accurate measurement of dynamic joint motion remains a clinical challenge. To address this problem, we have developed a low-dose clinical procedure using the Roentgen Single-plane Photogrammetric Analysis (RSPA) technique. A validation study was performed in a clinical setting, using a conventional digital flat-panel radiography system.

Method: To validate the technique, three experiments were performed: assessment of static accuracy, dynamic repeatability and measurement of effective dose. A knee joint phantom, imbedded with tantalum markers, was utilized for the experiments. Relative spatial positions of the markers were reconstructed using Radiostereometric Analysis (RSA). A digital flat-panel radiography system was used for image acquisition, and the three-dimensional pose of each segment was determined from single-plane projections by applying the RSPA technique. All images were processed using software developed in-house. To assess static accuracy, the phantom was mounted onto a three-axis translational stage and moved through a series of displacements ranging from 0 to 500 μm. Images of the phantom were acquired at each position. Accuracy was calculated by analyzing differences between reconstructed and applied displacements. To assess dynamic repeatability, the phantom was mounted on a six-axis robot, programmed to apply a flexion-extension movement to the joint. Multiple cine acquisitions of the moving phantom were acquired (30 fps, 4 ms exposure). Repeatability was calculated by analyzing the variation between motions reconstructed from repeated acquisitions. The effective dose of the procedure was measured using an ion-chamber dosimeter. The ion chamber was positioned between the phantom and x-ray source, facing the source. Entrance exposure was measured for multiple acquisitions, from which the effective dose was calculated.

Results: The accuracy determined from the static assessment was 25 μm and 450μm at the 95% confidence intervals for translations parallel and orthogonal to the image plane, respectively. Repeatability of the motion reconstructed from dynamic acquisitions was better than ± 200 μm for translations and ± 0.1 for rotations. The average effective dose for a 6 second dynamic acquisition was approximately 2μSv.

Conclusion: The proposed clinical procedure demonstrates both a high degree of accuracy and repeatability, and delivers a low effective dose.

Purpose: The growing trend of morbidly obese (BMI 40+) patients requiring a total joint replacement is becoming major concern in total knee Arthroplasty (TKA). The purpose of this study was to investigate the affects that BMI may have on implant longevity and clinical patient outcome using historical patient data.

Method: A consecutive cohort of 3083 TKA’s in 2048 patients since 1995 (minimum 2 years follow-up) were evaluated. Pre-operative scores, latest scores, and change in clinical outcome scores (KSCRS, SF12, WOMAC) were analyzed using ANOVA and Kaplan-Meier (K-M) survivorship was determined.

Results: K-M cumulative survival at 10 years by BMI group was 0.951±0.033 for Normal and Underweight (< 25, n=277), 0.944±0.024 for Overweight (25–29.9, n=915), 0.882±0.032 for Obese (30–39.9, n=1460) and 0.843±0.076 for Morbidly Obese (40+, n=352). Cumulative revision rates were 1.8% for Normal and Underweight, 1.9% for Overweight, 2.9% for Obese and 2.8% for Morbidly Obese. All pre-operative clinical scores were significantly different between the Morbidly Obese and all other BMI groups (p< 0.05), with the non-morbidly obese having higher scores in all cases. Significant difference was found in the change in WOMAC domain scores and the KSCRS knee score (p< 0.05) between the morbidly obese group and all other BMI groups, with the morbidly obese having the greatest improvement in all domains.

Conclusion: The morbidly obese patient cohort (BMI > 40) undergoing TKA demonstrated the most significant improvement in clinical outcome scores; however also had the lowest cumulative 10 year survivorship. This risk/benefit information is important in pre-operative discussions with this challenging, and increasingly prevalent, patient population.

Purpose: There are two broad-based categories of cementless femoral components performed during total hip arthroplasty: proximally coated versus fully porous coated. While both have enjoyed widespread clinical applications, there remains debate regarding differences in clinical outcome scores, relative incidence of thigh pain and the development of stress shielding. The purpose of this study was to investigate these variables in a multi-center prospective randomized blinded clinical trial.

Method: Between three centers 388 patients were enrolled in this clinical trial. 198 patients received a proximally coated tapered cementless femoral component (Synergy, Smith and Nephew, Memphis) and 190 patients received a fully porous coated cementless femoral component (Prodigy, Depuy, Warsaw). Patients were evaluated pre-operatively, at 3, 6, 12 months and annually thereafter, with multiple validated outcome measures including WOMAC, SF12, HSS, UCLA activity and thigh pain scores. A cohort of 72 patients underwent preoperative and postoperative DEXA scanning.

Results: 367 patients had a minimum of 2 years follow-up (average 6.4 years). There were no differences in age at surgery, BMI, or pre-operative clinical outcome scores (WOMAC, SF12, HSS, UCLA activity, thigh pain) between groups. There were no differences in any post-operative clinical outcome scores at any interval of follow-up. There were no differences in incidence of thigh pain between groups at any time. The only measurable difference between study groups was in bone mineral density evaluation. Bone density change in Gruen zone 7 was 23.7% with the Prodigy stem and 15.3% with the Synergy stem (p=0.011).

Conclusion: Both fully porous coated and proximally porous coated cementless stems performed well, with no clinical differences at a minimum of 2 years follow-up. Only bone mineral density evaluations could detect any differences between these femoral components designs.

Purpose: The increasing trend of morbidly obese patients (BMI 40+) requiring joint replacement is becoming a growing concern in Total Hip Replacement (THR) surgery. The purpose of this study was to investigate the influence that BMI may have on implant longevity and clinical outcome using prospectively collected patient data.

Method: A consecutive cohort of 2864 THR’s in 2488 patients with osteoarthritis and a minimum 2 years follow-up were evaluated. Patients were divided into appropriate BMI categories; Normal and Underweight (BMI< 25, n=650), Overweight (BMI 25–29.9, n=1069), Obese (BMI 30–39.9, n=981), and Morbidly Obese (BMI 40+, n=164). Pre-operative, latest, and change in clinical outcome scores (HSS, SF12, WOMAC) were analyzed using ANOVA and Kaplan-Meier (K-M) survivorship was determined. Categorical variables such as gender and survival status were analyzed using chi-squared.

Results: Morbidly Obese patients requiring THR’s were significantly younger than all other BMI groups by 5.4±0.83 years (p< 0.0001). Gender was also significant to BMI grouping with more females being Morbidly Obese and Normal or Underweight (p< 0.0001). All pre-operative and latest HHS and WOMAC domain scores were lower for the Morbidly Obese, significantly in all preoperative score domains and latest HHS Function (p< 0.05). The change in clinical scores from pre-operative to latest was greatest in all domains for the Morbidly Obese group. K-M cumulative survival with implant revision as the endpoint at 10 years was not different between the BMI groups. Revision rates for infection for the Morbidly Obese, Obese, Overweight, and Normal were 1.3%, 0.65%, 0.3% and 0.69% respectively. Overall Revision rates for the Morbidly Obese, Obese, Overweight, and Normal were 6.7%, 5.4%, 6.9% and 5.7% respectively and were not found to be significant (p=0.496).

Conclusion: The Morbidly Obese cohort undergoing THR had significantly lower preoperative and lower postoperative clinical outcome scores than all other BMI groups but demonstrated the most significant improvement. No difference was found in the K-M survivorship although revisions and revisions for infection were not equal between the groups

Purpose: The results of medial unicompartmental knee replacement have been reported as excellent over the intermediate term with both fixed and mobile bearing designs. However not all publications report equal success, with different outcomes also reported between mobile and fixed bearing designs. The purpose of this study was to compare the outcomes of mobile and fixed bearing medial unicompartmental arthroplasties.

Method: We evaluated the results of 230 consecutive medial unicompartmental knee arthroplasties (UKA) designs performed between 1989 and 2006 at a single academic centre (London Health Sciences Centre). Eighty mobile bearing UKA (63 patients, mean follow up3.2 years) and 160 fixed bearing UKA (117 patients, mean follow up 6.2 years) were reviewed. The mean age of the patients at the time of surgery was 66 years. Forty nine patients died at a mean of 12.7 years after the index arthroplasty. Patients were evaluated clinically using the Knee Society, WOMAC and SF12 outcome scores and radiographically using the Knee Society rating system.

Results: In the fixed bearing group 21 knees underwent revision at a mean of 6.9 years after the index procedure. In the mobile bearing group 7 knees underwent revision at a mean of 2.6 years. The mean Knee Society knee and function scores for the patients who had not had a revision improved in both groups, with the fixed bearing group mean function and Knee Society Scores improving from 53 and 48 points preoperatively to 80 and 93 points at the time of the most recent evaluation. In the mobile bearing group the mean function and Knee Society Scores improved from 55 and 44 points preoperatively to 85 and 91 points at the time of the most recent evaluation. The five year cumulative survival rates were 96% (SE +/− 0.18) and 89% (SE +/− 0.46) for the fixed and mobile bearing designs respectively, with ten year cumulative survival rates of 85% (SE +/− 0.35) in the fixed bearing group using an endpoint of revision to tricompartmental knee arthroplasty.

Conclusion: Both bearing designs of medial unicompartmental knee arthroplasty provided excellent pain relief and restoration of function in carefully selected patients and demonstrated durable implant survival over the midterm. In this study the fixed bearing designs demonstrated improved survivorship over the mobile bearing designs at 5 years. This may be related to the learning curve of the different bearing systems.

Purpose: The purpose of this study is to compare the clinical results of a standard polyethylene tibial insert versus the high flex polyethylene tibial insert component designs of a posterior cruciate substituting total knee replacement.

Method: One-hundred patients were entered into a prospective, randomized clinical trial comparing standard polyethylene tibial inserts versus the high flex polyethylene tibial insert component designs of posterior cruciate substituting total knee replacement(Genesis II, Smith & Nephew, Memphis, TN). Patients were evaluated pre-operatively, at 3, 12 months and annually thereafter. Patient demographics, radiographs, and multiple outcome measures (WOMAC, SF-12 and the Knee Society Clinical Rating System) were evaluated.

Results: No patients were lost to follow-up. One patient died prior to the two year follow up. Ninety- nine patients were reviewed at an average follow-up of 2.7 years (range 2.3 – 3.1 years). There were no significant differences in any outcome measures or radiographic findings. There were no differences in KSCRS at two years (Standard − 170, High Flex −171). There were no differences in knee flexion at 2 years (Standard− 125°, High Flex − 126°).

Conclusion: In this prospective randomized clinical trial, no differences could be seen between standard polyethylene and a “Hi- Flex” polyethylene design at a minimum of 2 years follow-up. In particular, no improvement in knee flexion was observed. Long-term evaluation will be required to comment on differences in polyethylene wear and implant longevity.

Purpose: The purpose of this study was to determine the clinical and radiographic outcomes at a minimum follow-up of ten years of patients who underwent a total knee arthroplasty with an inset patellar component. The incidence of anterior knee pain and the factors which may contribute to were also studied.

Method: Patients who had genesis I/II TKA with an inset patellar button with a minimum follow-up of 10 years were identified. 448 patients with 521 knees were identified. Patients were excluded if they were deceased, had incomplete data, were unable to be contacted or had a known or impending revision. Those who had revision were included in a Kaplan-Meier survivorship analysis. The included patients, deceased patients and those lost to follow-up were named group1, 2, and 3 respectively. Demographics and Knee society scores(KSS) were studies for all 3 groups. This was to identify any exclusion bias. Presence and severity of anterior knee pain as well as radiographic factors were collected for group 3. Logistic regression analysis was used to identify and variables that influenced the KSS and presence of anterior knee pain. Kaplan-Meier survivorship analysis was performed for patellar revision and tibial/femoral revision endpoints.

Results: 144 patients with 175 TKA were included in this study. They were on average 66 years old, 64% female, had a BMI of 30 and had a diagnosis of OA 92% of the time. Their average f/u was 11.3 years. Groups 2 and 3 had similar demographics but of course a much shorter f/u. Group 1 had a pre-op KSS of 84 a post-op KSS of 151 and a KS change score of 67. Groups 2 and 3 had similar pre-op, post-op and KSS change scores. We found anterior knee pain occurred in 5% of patients with an average severity of 5/10. Linear regression analysis did not identify any variables including radiographic parameters that had an independent influence on KSS or anterior knee pain. Kaplan-Meier survivorship with patellar revision for any reason as an endpoint was 96% at 10 years and 94% at 17 years. 20 patella were known to have had a revision or were undergoing a revision.

Conclusion: We conclude that use of an inset patellar component can give excellent durable results over time with a low rate of anterior knee pain and complications

Purpose: Gender specific total knee replacement design has been a recently debated controversial topic. The purpose of this study was to investigate the survivor-ship and clinical outcomes of a large primary total knee arthroplasty cohort, specifically assessing any differences between gender groups.

Method: A consecutive cohort of 3817 patients with osteoarthritis, having undergone 5289 primary total knee replacements (3100-female, 2179-male) with a minimum of 2 years follow-up were evaluated. All surgeries were performed at the same institution by one of four surgeons. Pre-operative scores, latest scores, and change in clinical outcome scores (KSCRS, SF12, WOMAC) were compared and tested for significance using the students t-test. Kaplan Meier (K-M) survivor-ship was determined and tested for significance and categorical variables were compared using chi-squared.

Results: Men were significantly taller and heavier than women, while women had significantly higher BMI’s (p< 0.0001). While men had higher raw scores preoperatively, women demonstrated statistically greater improvement (p< 0.019) in all WOMAC domains including pain (29.87 vs. 27.30), joint stiffness (26.78 vs. 24.26), function (27.21 vs. 23.09) and total scores (28.34 vs. 25.09) There were no gender differences in improvements of the SF12 scores. Men demonstrated statistically greater improvement (p< 0.0001) in Knee Society function (22.10 vs. 18.63) and total scores (70.01 vs. 65.42), but not the Knee Society knee score (47.83 vs. 46.64, p=0.084). K-M cumulative survivorship at 10 years was 87.4±.01 for females and 82.9±.014 for males. K-M survivorship distribution was found to be significantly different between gender groups (p< 0.013, Mantel-Cox, Breslow, Tarone-Ware). Revision rates were 10.2% for males and 8.3% for females which was found to be significant by crosstabs with chi-squared (p=0.006).

Conclusion: In this cohort of patients undergoing total knee replacements, women demonstrated statistically greater implant survivorship, statistically greater improvement in WOMAC scores and less improvement in KSCR scores, leading one to question the hypothesis of an inferior clinical outcome in total knee arthroplasty that is gender based.

The purpose of this study was to assess the influence of patient factors on six to eleven year TKR outcomes.

Three hundred and sixty-five consecutive patients (436 Genesis II TKR’s) were prospectively analyzed according to gender, diagnosis, body mass index, pre-operative deformity, pre-operative range of motion and implant type.

The Kaplan-Meier survivorship for the TKR patients was 98% ±.8% at nine years. Large and significant improvement in pre-operative health related quality of life (HRQL) outcomes (KSCR, WOMAC and SF-12) were noted Female patients demonstrated significantly worse pre-operative and post-operative KSCR, WOMAC and SF-12 scores but similar change scores and decreased post-operative range of motion compared to their male counterparts. Patients with rheumatoid arthritis had significantly inferior pre-operative and post-operative HRQL indices, but similar change scores. Rheumatoid patients achieved greater post-operative range of motion than patients with osteoarthritis. Patients with a body mass index > 30 had significantly less pre-operative and one year range of motion, but beyond two years follow-up health-related quality of life indices and range of motion were similar to other BMI categories. Pre-operative deformity did not affect patient outcome. Pre-operative range of motion had a significant effect on post-operative range of motion. Comparable outcomes were achieved with both posterior cruciate ligament preserving and sacrificing total knee replacements; however, the posterior cruciate ligament sacrificing implants had significantly greater postoperative range of motion.

With a contemporary total knee replacement with 98% Kaplan-Meier survivorship at nine years, male gender, a diagnosis of osteoarthritis and a good pre-operative range of motion were indicators of improved post-operative outcomes. Change scores of health-related outcomes are a better indicator of efficacy than simply noting pre- and post-operative scores.

In patients with previous patellectomy the optimal constrained implant is not well understood. Previous outcome studies have shown contradictory results. There interpretation is limited by small number of patients, included primary and revision implants or involved a heterogeneous group of different constraint implants.

We performed retrospective match controlled analysis of a posterior stabilised primary total knee arthroplasty in forty-two patients who had previous patellectomy. There were nineteen male and twenty-three female patients. The average age of patients at the time of surgery was fifty-nine years (range from forty-one to seventy-four years). The average time from patellectomy to total knee arthroplasty was seventeen years (range from one to thirty-four years). The average duration of follow-up was 5.3 years with minimum two years follow up (range from two to sixteen years). The control group was matched by age, sex, prosthesis type and surgeon. We used the student-t test to compare the outcome measurement.

Preoperatively, the patellectomy and control groups were not significantly different in terms of Knee Society clinical and functional scores or range of motion. Postoperatively clinical component of the knee society score had a significant difference (p< 0.05) however the functional part of the knee society score didn’t (p> 0.05). In patellectomy group the postoperative clinical and functional score were equal to seventy and fifty-eight respectively. The average clinical component of knee society score in the patellectomy group was twelve points (SE=4.8) lower compare to the knee with intact patella. The patellectomy group also had higher extension lag and poorer extension (higher flexion contracture) at the most recent follow up (p< 0.05).

This study demonstrated the outcome of the largest series of primary total knee arthroplasty with posterior stabilised implant in patient with previous patellectomy. The outcome of surgery was significantly improved but not as good as the knee with intact patella especially the function of the extensor mechanism.

This study reports on the clinical and wear performance of a prospective randomised controlled trial comparing highly cross-linked (XLPE) to conventional polyethylene (PE) in total hip arthroplasty at five years minimum follow-up.

One hundred patients enrolled in a prospective randomised controlled trial received identical hybrid total hip arthroplasties with the exception of the polyethylene insert. Fifty patients received a PE liner (2.5 MRads; gamma-in-nitrogen sterilization) and fifty patients received a XLPE liner (10Mrads; gas-plasma sterilization). Clinical outcomes were determined using Harris Hip, WOMAC and SF-12 scores by an independent study nurse. Femoral head penetration rates were determined using a validated radiographic technique (Hip Analysis Suite 8.0.1.1) based on radiographs at six weeks, one year and yearly post-operatively. Linear regression analysis was performed for both the entire polyethylene groups and on each patient, where the slope represents the steady state head penetration rate (after bedding in) from one to five years follow-up.

None of the patients were lost to follow-up, however, nine patients were deceased before their five year follow-up. Two patients have been revised for loose stems. At average follow-up of 6.0 years (range 5.1–6.8 years), there were no differences in Harris Hip, WOMAC or SF-12 scores. XLPE had a significantly lower (p= 0.03) steady-state head penetration rate of 0.018 mm/year compared to 0.050 mm/year for XLPE (approximately 64% reduction). Analysis of individual patient’s head penetration rates demonstrated a similar significantly lower rate with XLPE (0.004 ± 0.067 mm/year) compared to PE (0.045 ± 0.083 mm/year). Interestingly, when examined by gender, the male PE group had a significantly higher head penetration rate (0.081 ± 0.084 mm/year) than both the male and female XLPE (−0.013 ± 0.104, 0.011 ± 0.074 mm/year, respectively).

At minimum five years follow-up, there were no clinical differences between groups. After bedding-in, there was a significant lower head penetration rate with XLPE compared to PE. Thus, mid-term follow-up appears to demonstrate a significant wear reduction (based on head penetration rates) afforded by first generation XLPE. Long-term follow-up is required to demonstrate the clinical benefit of this new material.

The purpose of this study was to evaluate the impact of dalteparin use on transfusion rates and blood loss in patients undergoing primary total joint arthroplasty at our center.

We prospectively studied the transfusion patterns of 1642 patients who underwent primary total hip or knee arthroplasty between January 2004 and December 2005 by five arthroplasty surgeons. The influence of daltaperin use, release of tourniquet in total knee arthroplasty, and the turnover of house staff were analyzed using SPSS V14.0 statistical software.

We identified seven hundred and three total hip and nine hundred and thirty-nine knee arthroplasty patients. The mean haemoglobin drop was statistically significant between 2004 and 2005 (p< 0.001). This was seen in both hip (p=0.014) and knee (p< 0.001) patients. Subgroup analysis of total knee arthroplasty revealed a significant difference in haemoglobin drop between surgeons who released the tourniquet prior to closure compared to release at the end of the case (p=0.005). In addition, there were significant monthly differences that corresponded with the turnover of house staff (p=0.039). Overall, no statistically significant increase in allogeneic transfusion rates was observed between years, months, and individual surgeons.

The use of dalteparin was found to be associated with a significantly increased haemoglobin drop in primary total joint replacement when compared to warfarin. However, the use of dalteparin was not associated with an increase in allogeneic transfusions at our center. The results also suggest that there may be an advantage to releasing the tourniquet and achieving hemostasis prior to closure in knee arthroplasty. Finally, the results emphasise the importance of educating new house staff on methods to reduce intra-operative blood loss and transfusion rates.

Background: Post-operative analgesia using parenteral opioids or epidural analgesia can be associated with troublesome side effects.

Locally administered pre-emptive analgesia is effective, reduces central hyper sensitisation and avoids systemic drug related side-effects and may be of benefit in total knee replacement.

Materials and Methods: 64 patients undergoing total knee replacement were randomised to receive a periarticular intra-operative injection containing ropivacaine, ketorolac, epimorphine and epinephrine or nothing.

All patients received patient controlled analgesia (PCA) for 24 hours post surgery, followed by standard analgesia. Visual Analogue Scale (VAS) pain scores during activity and at rest and patient satisfaction scores were recorded pre and post operatively and at 6 week follow up. PCA consumption and overall analgesic requirement were measured.

Results: PCA use at 6,12 and over 24 hours post surgery was significantly less in patients receiving the injection (P< 0.01, P=0.016, P< 0.01). Patient satisfaction in PACU and 4 hrs post operation was greater (P=0.016, P=0.013). VAS for pain during activity in PACU and at 4 hrs were significantly less (P= 0.04, P=0.007) in the injected group. The average ROM at 6 weeks was no different. Overall hospital stay and the incidence of wound complications was not different between the two groups.

Conclusion: Peri-articular intra-operative multimodal analgesia significantly reduces post-operative PCA requirement. Patient satisfaction was greater in the injection group.

Femoral stem fracture occurred in five (2%) of 283 revision hip arthroplasties when extensively coated, distal fixation femoral implants were used. Common features were complex revisions, high body mass index, poor proximal support, smaller stems (< 13.5 mm) and use of an extended trochanteric osteotomy. Use of strut allografts can reduce femoral stem stresses.

The purpose of this study was to analyze the surgical factors associated with fracture of cementless distal fixation revision femoral stems and supplement this analysis with a finite element analysis.

Data from our institutional joint replacement database identified five (2%) fractured femoral stems (three Solution, two Echelon) in a cohort of two hundred and eighty-three cementless distal fixation femoral stems (one hundred and eighty-two Solution, one hundred and one Echelon) followed over two years. Patient, surgical and implant factors were compared between the fractured and not fractured stems. Finite element analysis was performed on two fractured stem cases to better understand the fracture mechanism.

Common clinical features of the five fractured stems were complex revisions, high patient body mass index, poor proximal bone support, smaller stems (< 13.5 mm) and use of an extended trochanteric osteotomy (ETO) (3/5). Fatigue failure was the mode failure in all cases.

Finite element analysis confirmed that the location of highest stem stress was near the location of the stem fracture and that use of a strut graft over an extended trochanteric osteotomy in patients lacking proximal femoral cortical support decreased the stem stresses by 48%.

Use of cementless distal fixation revision femoral stems is accompanied by a 2% risk of stem fracture in the face of proximal femoral support of the stem and/or use of a stem with a diameter less than 13.5 mm. When an extended trochanteric osteotomy is used, the stem fracture rate increased to 4%. Use of a strut allograft in conjunction with the ETO can reduce stem stresses by 48% and the risk of stem fracture.

Funding: Research support from J& J DePuy and Smith & Nephew

In recent years articulating cement spacers have been used to treat infected knee arthroplasty. The aim has been to better maintain tissue planes and joint mobility thereby improving second stage re-implantation surgery. Two groups of patients treated for infected knee arthroplasty were reviewed. Twenty-six patients with articulating and forty patients with static antibiotic-impregnated methyl-methacrylate spacers were compared. The articulating spacers demonstrated easier surgical exposure at second stage and improved range of knee motion after re-implantation. There was no compromise in the rate of infection eradication with articulating spacers. Bone loss at revision was independent of spacer type.

To compare the results of patients treated with articulating versus static antibiotic-impregnated spacers for infected knee arthroplasty.

Articulating cement spacers facilitate re-implantation surgery by maintaining tissue planes and joint mobility without compromising joint stability or eradication rate of infection. Patients demonstrate better range of motion and less complications related to the extensor mechanism with the articulated spacer.

Antibiotic impregnated methyl-methacrylate spacers have become a mainstay in two-stage revision arthroplasty for sepsis. It is thought that articulating cement spacers facilitate prosthesis re-insertion by better maintaining tissue planes and joint mobility between stages.

In the articulating group fewer extensile exposure methods were required at second stage prosthesis reimplantation (19% vs 36 %). No tibial tuberosity osteotomies have been required since using the articulating spacer. The articulating group demonstrated a significantly improved range of flexion compared to the static group(106 vs 97 degrees- p=0.045) and had fewer patients with significant loss of extension or quadriceps lag. Eradication of infection was improved in the articulating group (92% vs 82%) but at shorter average follow-up. The need for augments and stabilized prostheses at revision surgery as a measure of bone loss was no different between the groups but was related to the number of prior surgical procedures.

Twenty-six patients treated with articulating spacers were compared to a matched consecutive group of forty patients treated with static spacers. Minimum follow-up was twelve months from second stage re-implantation (average twenty-two months articulating, forty months static)

Funding: No direct funding from any commercial source has been received for this study. The primary author’s fellowship position is partially funded by Smith and Nephew Richards Inc.